SRXH — SRx Health Solutions Inc.

Summary of Better Choice Company (SRXH) Q4 2024 Earnings Call

1. Key Financial Results and Metrics

• Annual Net Revenues: $35 million, down 9% year-over-year due to strategic exits from non-core sales channels.
• Q4 Revenue Growth: $7.2 million, a 26% increase year-over-year, driven by a 32% growth in key digital platforms (Amazon and Chewy).
• Gross Profit Margin: Improved to 37%, up over 600 basis points year-over-year.
• Adjusted EBITDA Loss: Approximately $1.9 million for the full year, an improvement of 78% year-over-year; Q4 adjusted EBITDA loss improved by 80% to approximately $700,000.
• Net Loss: Full year EPS loss of $0.11, significantly improved from a loss of $32 per share in 2023.
• Cash Position: Cash and cash equivalents at $3 million; net working capital increased over 200% to $7.9 million.

2. Strategic Updates and Business Highlights

• Turnaround Strategy: Focused on improving profitability and operational efficiency, leading to a 22% reduction in SG&A expenses.
• E-commerce Focus: Increased emphasis on digital sales channels, with successful promotions during Black Friday contributing to revenue growth.
• International Expansion: Notable growth in international markets, particularly in Asia, with a 18% increase in international revenue.
• Debt Management: Successfully extinguished significant debt obligations, resulting in a $6.2 million gain, improving financial flexibility.
• Royalty Agreements: Signed agreements to sell Halo Asian operations for $6.5 million in cash and a 3% royalty on sales, alongside a 5.5% royalty agreement for Halo Elevate brand sales.

3. Forward Guidance and Outlook

• Positive Momentum: Entering 2025 with optimism, expecting continued growth in e-commerce and improved financial health.
• Strategic Acquisition: Anticipated closing of the SRx Health acquisition in April 2025, expected to enhance operational efficiencies and growth opportunities.
• Shareholder Returns: Commitment to distributing up to 55% of annual royalties generated by the Halo brand to shareholders.

4. Bad News, Challenges, or Points of Concern

• Revenue Decline: Overall annual revenues decreased due to strategic exits from less profitable sales channels, indicating potential risks in maintaining top-line growth.
• Market Conditions: Ongoing consumer uncertainty related to geopolitical factors and tariffs could impact future sales and profitability.
• Competitive Pressures: The pet food industry remains competitive, necessitating continuous innovation and marketing effectiveness to retain market share.

5. Notable Q&A Insights

• The call concluded without a Q&A session, limiting insights into investor concerns or additional clarifications on the financial results or strategic initiatives.

Overall, Better Choice Company demonstrated significant improvements in financial metrics and operational efficiency in Q4 2024, positioning itself for continued growth despite challenges in the broader market. The strategic focus on e-commerce and international expansion, along with the upcoming acquisition of SRx Health, are key elements of their growth strategy moving forward.